Search Results - "Shotaro Nakamura"

Refine Results
  1. 1
  2. 2

    Gastrointestinal lymphoma: recent advances in diagnosis and treatment by Nakamura, Shotaro, Matsumoto, Takayuki

    Published in Digestion (01-01-2013)
    “…The recent trends in the diagnosis and management of gastrointestinal lymphoma are reviewed. Primary gastrointestinal lymphoma accounts for 30-40% of all…”
    Get more information
    Journal Article
  3. 3

    Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma by Nakamura, Shotaro, Hojo, Mariko

    Published in Journal of clinical medicine (23-12-2022)
    “…Mucosa-associated lymphoid tissue (MALT) lymphoma, which was first reported in 1984, shows an indolent clinical course. However, the detailed…”
    Get full text
    Journal Article
  4. 4

    Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era by Ishikawa, Eri, Nakamura, Masanao, Satou, Akira, Shimada, Kazuyuki, Nakamura, Shotaro

    Published in Cancers (17-01-2022)
    “…Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) typically arises from sites such as the stomach, where there is no…”
    Get full text
    Journal Article
  5. 5

    Effect of Halogens in Bis(haloaryloxyl)pyrazine Host Crystals on the Room Temperature Phosphorescence Properties of Bisbenzofuropyrazine Guest Luminophores by Tsuboi, Madoka, Nakamura, Shotaro, Nishii, Yuji, Tohnai, Norimitsu, Miura, Masahiro

    Published in Chemistry letters (05-08-2022)
    “…Several title host crystals including guest luminescent compounds exhibit apparent room temperature phosphorescence (RTP) along with fluorescence under…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Nakamura, Shotaro, MD, PhD, Matsumoto, Takayuki, MD, PhD

    Published in Gastroenterology clinics of North America (01-09-2015)
    “…Recent trends and current knowledge on the diagnosis and treatment strategy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma are reviewed…”
    Get full text
    Journal Article
  8. 8

    Immune checkpoint inhibitor‐induced diarrhea: Clinicopathological study of 11 patients by Yanai, Shunichi, Nakamura, Shotaro, Kawasaki, Keisuke, Toya, Yosuke, Akasaka, Risaburo, Oizumi, Tomofumi, Ishida, Kazuyuki, Sugai, Tamotsu, Matsumoto, Takayuki

    Published in Digestive endoscopy (01-05-2020)
    “…We reviewed the records of patients with immune checkpoint inhibitor (ICI)‐induced diarrhea during 2015 to 2019. ICI included nivolumab and ipilimumab. There…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Syntheses and Room Temperature Phosphorescence Properties of Dibenzobenzodithiophenes and Dibenzothiophenes by Tsuboi, Madoka, Nakamura, Shotaro, Nandi, Surajit, de Silva, Piotr, Takeda, Youhei, Miura, Masahiro

    Published in Bulletin of the Chemical Society of Japan (15-10-2021)
    “…A new family of heavy-atom-free room-temperature phosphorescent compounds, dibenzobenzodithiophenes (DBDTs) have been synthesized and characterized. The…”
    Get full text
    Journal Article
  13. 13

    Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series by Urushikubo, Jun, Yanai, Shunichi, Nakamura, Shotaro, Kawasaki, Keisuke, Akasaka, Risaburo, Sato, Kunihiko, Toya, Yosuke, Asakura, Kensuke, Gonai, Takahiro, Matsumoto, Takayuki

    Published in Internal Medicine (15-08-2019)
    “…Objective Indigo naturalis (IN) is a traditional Chinese medicine that has recently been reported to be effective for ulcerative colitis (UC). The aim of this…”
    Get full text
    Journal Article
  14. 14

    Risk Factors for Post-gastric Endoscopic Submucosal Dissection Bleeding with a Special Emphasis on Anticoagulant Therapy by Toya, Yosuke, Endo, Masaki, Oizumi, Tomofumi, Akasaka, Risaburo, Yanai, Shunichi, Kawasaki, Keisuke, Nakamura, Shotaro, Eizuka, Makoto, Fujita, Yasuko, Uesugi, Noriyuki, Sugai, Tamotsu, Matsumoto, Takayuki

    Published in Digestive diseases and sciences (01-02-2020)
    “…Background Little is known about the risk factors for post endoscopic submucosal dissection (post-ESD) bleeding with anticoagulant therapy. Aims We aimed to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Dabigatran-induced esophagitis: The prevalence and endoscopic characteristics by Toya, Yosuke, Nakamura, Shotaro, Tomita, Kazumitsu, Matsuda, Nozomi, Abe, Keinosuke, Abiko, Yukito, Orikasa, Shunsuke, Akasaka, Risaburo, Chiba, Toshimi, Uesugi, Noriyuki, Sugai, Tamotsu, Matsumoto, Takayuki

    Published in Journal of gastroenterology and hepatology (01-03-2016)
    “…There have been some descriptions of dabigatran-induced esophagitis in the literature. The aim of this study was to examine the prevalence and endoscopic…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Anti‐Helicobacter pylori therapy in localized gastric mucosa‐associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan by Sugizaki, Katsuya, Tari, Akira, Kitadai, Yasuhiko, Oda, Ichiro, Nakamura, Shotaro, Yoshino, Tadashi, Sugiyama, Toshiro

    Published in Helicobacter (Cambridge, Mass.) (01-04-2018)
    “…Background Helicobacter pylori eradication therapy was approved in Japan for the first‐line, standard treatment of H. pylori‐positive gastric mucosa‐associated…”
    Get full text
    Journal Article
  20. 20